91ÊÓƵ

Adjunct Professor David Shine has worked in the mergers & acquisitions/private equity space for over 30 years. Currently, he runs DNS Consulting LLC, which provides a broad range of strategic advice to startups, with a focus on food & beverage, software services, and technology platforms.

Previously, he was a partner at the international law firms Fried Frank LLP and Paul Hastings LLP. At both firms he ran the mergers & acquisitions practices. Highlights from his practice include representations of Merck in its $40 billion acquisition of Schering Plough and its $15 billion disposition of its consumer products business, Goldman Sachs in its $29 billion acquisition of First Data and $45 billion acquisition of TXU, Northrop Grumman in its $6 billion acquisition of Newport News Shipbuilding, and numerous private equity firms in their purchase and sale transactions.

• BA, Columbia University
• JD, NYU School of Law

• Advising Startups LAW 731

• Solving the Valuation Puzzle in Life Sciences Transactions: The Pros and Cons of the CVR, The M&A Lawyer
• M&A Transactions in the Aerospace and Defense Industry, Practical Law The Journal
• Antitrust Termination Fees: Rational or Emotional?, The M&A Lawyer
• A Practical Approach to Negotiating Confidentiality Agreements in the Corporate Acquisition Context, The M&A Lawyer
• Reverse Termination Fees Gone Wild: Legal Limits or Sky’s the Limit?, The M&A Lawyer

• ‘Dealmaker of the Year’ by The American Lawyer
  ‘Dealmaker of the Year’ by Finance Monthly
  ‘Life Sciences MVP’ by Law 360
  ‘Leading Lawyer, Corporate/M&A’ for 12 consecutive years by Chambers USA

Startups, Private Equity, Mergers & Acquisitions